Aim: The aim of this study was to investigate the effects of aloe-emodin, a natural compound from the root and rhizome of Rheum palmatum, on the growth of human cervical cancer cells, HeLa. Methods: HeLa cells were treated with various concentrations of aloe-emodin for 1-5 d, and cell growth was measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide assay. The long-term growth effect was investigated by crystal violet assay. The distributions of the cell cycle and apoptosis were analyzed by flow cytometry. The alkaline phosphatase (ALP) activity was analyzed by a chemical analyzer. Finally, Western blotting was used to indicate the abundant changes of protein kinase C (PKC), cmyc, cyclins, cyclin-dependent kinases (CDK), and proliferating cell nuclear antigen (PCNA). Results: Aloe-emodin inhibited the growth of HeLa cells in a dosedependent manner at concentrations ranging between 2.5 and 40 µmol/L. The flow cytometric analysis showed that HeLa cells were arrested at the G 2 /M phase. This effect was associated with the decrease in cyclin A and CDK2, and the increase in cyclin B1 and CDK1. More importantly, the ALP activity was found to be increased by aloe-emodin treatment, and accompanied by the inhibition of PCNA expression. In addition, aloe-emodin suppressed the expression of PKCα and c-myc. Conclusion: These findings provide a possible mechanistic explanation for the growth inhibitory effect of aloe-emodin on HeLa, which includes cell cycle arrest and inducing differentiation.
Introduction
There is an increasing demand for natural compounds that improve humans' health. Many nutritive and non-nutritive phytochemicals with diversified pharmacological properties have shown promising responses for the prevention and/or intervention of various cancers [1] . Aloe-emodin (1,8-dihydroxy-3-hydroxymethyl-9,10-anthracenedione) is a herbal anthracenedione derivative from Rhei rhizoma, a traditional Oriental herb commonly used in laxation, antivirus, and hepatoprotection practice [2] [3] [4] . Recent reports have shown that aloe-emodin possesses antiproliferation effects on some types of cancer cells, such as lung squamous, glioma, and neuroectodermal cancer cells [5] [6] [7] . The anticancer mechanisms of aloe-emodin involve the induction of caspase-dependent apoptosis, where the greater sensitivity of neuroectodermal tumor cell lines could be related to an energy-dependent pathway [5, 7] . Furthermore, the antiglioma action of aloe-emodin involves extracellular signal-regulated kinases (ERK) 1 and 2-independent induction of both apoptosis and autophagy, as well as the ERK inhibition-mediated differentiation of glioma cells [6] . The inhibitory effect of aloe-emodin on the activity and gene expression of N-acetyltransferase, which plays an initial role in the metabolism of arylamine carcinogens, was found in human malignant melanoma cells [8] . Recently, Lin et al found that aloe-emodin-induced apoptosis in T24 human bladder cancer cells was mediated through the activation of p53, p21, Fas/Apo-1, Bax, and caspase-3 [9] . However, the anticancer molecular mechanisms of aloe-emodin are largely unclear, especially for cervical cancer cells.
Cervical cancer continues to be a major public health problem in the world. Of all neoplasms found in females around the world, cervical cancer has the third highest incidence and is the number four cause of death [10, 11] . In this study, in order to probe the mechanisms underlying the chemopreventive potential of aloe-emodin on cervical cancer, its effects on cell growth, cell cycle, alkaline phosphatase (ALP) activity, protein kinase C (PKC), and c-myc expressions in HeLa cells were investigated. The results of the present study demonstrated the ability and detail mechanisms of aloe-emodin with the potential anticancer therapeutic activity of cervical cancer. In all the assays, the vehicle (Me 2 SO) was present at less than 0.1% and the controls with the vehicle (0.1% Me 2 SO) were carried out in parallel.
Materials and methods

Materials and cell line
MTT assay Sets of 12 wells were used for each dose in this assay. In total, 30 µL MTT solution [2 g/L in phosphatebuffered saline (PBS)] was added into each of the 96 wells. After the cells were incubated at 37 o C for 4 h, the medium was removed and 150 µL of Me 2 SO was added to solubilize the formazan. The microplate was shaken on a rotary platform for 10 min. Finally, the optical density (OD) values were measured at 550 nm using a Wellscan reader (Labsystems, Santa Fe, NM, USA). The inhibitive rate was used to indicate the suppressive effect of aloe-emodin on the HeLa cells. Growth inhibition was calculated as a percentage as follows: ([OD control -OD experiment ]/OD control )×100% [12] .
Crystal violet assay
The intensity of crystal violet staining is directly proportional to the number of adherent cells [13] . In order to observe the long-term antiproliferation effect, the HeLa cells were seeded in flat-bottom 6-well plates at 1×10 4 cells/well and treated with various concentrations of aloeemodin for 8 d. Then the medium was removed very carefully by mild suction, and 2 mL/well of 1% glutaraldehyde solution in PBS was added. The plates were incubated for 15 min at room temperature to fix the cells. The fixative was removed and replaced by the same amount of PBS. The PBS was removed and the same amount of 0.02% aqueous solution of crystal violet was added. After incubation at room temperature for 30 min, the crystal violet solution was poured and the plates were washed gently with water. Then 2 mL 70% ethanol was used to release crystal violet. Finally, the absorbance was measured at 570 nm using a Wellscan reader.
Cell cycle analysis and apoptosis measurement A total of 1×10 6 HeLa cells were treated with various concentrations of aloe-emodin for 1-5 d. The cells were harvested with 0.25% trypsin and sedimented by centrifugation at 937×g for 5 min at room temperature. After the supernatant was removed, ice-cold 70% ethanol was added. Finally, the cell cycle was analyzed with a Coulter flow cytometer (Beckman Coulter, Miami, FL, USA). The cell cycle distribution was estimated according to standard procedures [14] . The percentage of cells in the different cell cycle phases (G 0 /G 1 , S, or G 2 /M phase) was calculated using Coulter Epicx XL-MCL DNA analysis software (Beckman Coulter, USA). The sub-G 1 peak was considered a measure of apoptosis [15, 16] .
Determination of relative ALP activities
The HeLa cells were seeded at a density of 1×10 4 and treated with 2.5, 5, 10, 20, and 40 µmol/L aloe-emodin for 1-5 d before being assayed for ALP activity. The cells were then dissolved with 0.25% sodium deoxycholate. Finally, the ALP activities were measured by dynamics assay with a Screen Master 3000 semiautomatic biochemistry analyzer (Hospitex Diagnostics, Florence, Italy). The relative enzyme activity was expressed as U/g [17, 18] . Six wells of a 12-well plate were used for each dose and treatment time. Three independent experiments were performed in this analysis.
Western blotting Total cell lysates from 2×10 5 cells were prepared by lysing the washed cell pellet directly in radioimmunoprecipitation buffer. The lysates were clarified by centrifugation at 13 000×g for 15 min at 4 °C. The lysates were boiled and separated by SDS-PAGE in 10% polyacrylamide gels, blotted onto a polyvinylidene fluoride membrane (Millipore, Bedford, MA, USA) and analyzed by Western blotting with the antibodies from Boster Bioengineering (Wuhan, China).
Statistics The statistical analysis was performed using SPSS version 10.0 (SPSS, Chicago, IL, USA). The Student's t-test was used to make a statistical comparison between the groups. The level of significance was set at P<0.05.
Results
Growth inhibitory effect of aloe-emodin on human cervical cancer cells The effect of aloe-emodin on cell growth was evaluated by MTT assay ( Figure 1A) . Aloe-emodin inhibited the growth of HeLa cells in a time-and dosedependent inhibitory manner at concentrations of 2.5-40 µmol/L (at 2.5 µmol/L-20 µmol/L, P<0.01; at 40 µmol/L, P<0.001). Next, to observe the long-term effect, the crystal violet assay was used. The results showed that the number of adherent cancer cells was decreased by aloe-emodin (P<0.001, Figure 1B) . These data imply that aloe-emodin has a significant growth inhibitory effect on HeLa cells in vitro.
Effect of aloe-emodin on the cell cycle progression of HeLa cells
In order to decipher the suppressive mechanisms of aloe-emodin on HeLa cells, changes in the cell cycle distribution were monitored by flow cytometry. The treatment of aloe-emodin resulted in a time-dependent increase in the distribution of cells at the G 2 /M phase (Table 1) . Furthermore, the sub-G 1 peak (apoptosis peak) was not observed (data not shown). By using DNA fragmentation analysis, the DNA ladder was not obviously observed (data not shown). Next, the levels of the cell cycle-associated proteins were determined by Western blotting. As shown in Figure 2 , aloe-emodin decreased the abundance of cyclin A and cyclin-dependent kinase (CDK) 2, while increased cyclin B1 and CDK1 in the protein levels in a dose-dependent manner. Such data were consistent with arresting cells in the G 2 /M boundary. Cyclins function as regulators of CDK. Cylin A binds and activates CDK2, and thus promotes both cell cycle G 1 /S and G 2 /M transitions [19] . Cyclin B1 binds and activates CDK1, and is expressed predominantly during the G 2 /M phase [20] . The results obtained from this study suggest that one of the mechanisms of the growth inhibitory effect of aloe-emodin on HeLa cells is through cell cycle arrest, but not by apoptosis induction, at least at the concentrations observed.
Increase of ALP activity by aloe-emodin In order to determine whether aloe-emodin is capable of affecting ALP activity in HeLa cells, a dynamics assay was used. The ALP activity was increased by aloe-emodin and reached its peak level at 5 d ( Figure 3A) . The statistical significance between the ALP of the control and treated cells was observed (5 µmol/L, P<0.05; 10, 20, and 40 µmol/L, P<0.01). As the proliferating cell nuclear antigen (PCNA) is a commonly used marker of both cell proliferation and differentiation [21] , its changes in the protein level was studied by Western blotting. As shown in Figure 3B , aloe-emodin decreased the abundance of PCNA.
Aloe-emodin decreases PKCα and c-myc in HeLa cells
As both the PKC pathway and c-myc participate in a wide range of cellular programs controlling proliferation, differentiation, and survival, the influence of aloe-emodin on the activation of these important signaling molecules in HeLa cells was examined. Western blotting results showed that the PKCα and c-myc protein levels in the control group was high, while after treatment with aloe-emodin, both decreased (Figure 4) . A clear dose-dependent decrease was found in cancer cells treated by aloe-emodin (Figure 4) .
Discussion
Phytochemicals present in medicinal herbs and dietary plants are one of the most attractive approaches in cancer chemotherapy. Aloe-emodin, a hydroxyanthraquinone from Rhei rhizoma leaves, has been found to have anticancer effects in several cancer cell lines [5] [6] [7] . More importantly, aloe-emodin was found to have no appreciable toxic effects in vivo [7] . Until now, the effect of aloe-emodin on cervical cancer has been largely unknown.
The results of the present study clearly demonstrate the anticancer activity of aloe-emodin on human cervical cancer HeLa cells. Aloe-emodin inhibited the growth of HeLa cells in a dose-dependent manner from 2.5 µmol/L to 40 µmol/L ( Figure 1A ). At the same time, crystal violet assays indicated that aloe-emodin has a durable growth inhibition on cervical cancer cells ( Figure 1B) .
To examine the mechanism responsible for cell growth inhibition, cell cycle distribution was evaluated using flow cytometry. The loss of the proliferative capacity of cervical cancer cells treated by aloe-emodin was associated with the G 2 /M phase arrest (Table 1) . At the same time, the cell cycleassociated proteins were obviously involved (Figure 2 ). Similar to our observations, several other studies found that aloeemodin blocked human glioma U251 cells and promyelocytic leukemia HL60 cells at the G 2 /M phase [6, 22] , and hepatoma cells at the G 0 /G 1 phase [23] . These suggest that multiple mechanisms may be responsible for the anticancer effects of aloe-emodin on different types of cancers.
Cellular ALP are increasingly recognized as important markers for monitoring tumor cell behavior in human malignancies. The measurement of ALP activity is usually used to determinate the effect of inducing the differentiation of anticancer reagents [24] . Early in vitro studies showed that some drugs, such as Ara C, peptichemio, or hydrocortisone, inhibited HeLa cell growth with the elevation of ALP activity [25] . In this study, the ALP activity in HeLa cells treated by aloeemodin increased in a time-and dose-dependent manner ( Figure 3A) . This is one of the first studies to focus on the expression of ALP in human cervical carcinomas cells treated by aloe-emodin.
Cell signal pathways have been become the targets for many drugs. Among them, the PKC pathway is gaining more and more attention for cancer chemotherapy. Several studies have shown that PKCα plays a role in tumor proliferation and survival [26, 27] . In this study, we found that PKCα was suppressed by aloe-emodin (Figure 4 ). These data strongly suggest that PKCα is one of the key targets of the antitumor action of aloe-emodin. To test this hypothesis, we observed the expression change of c-myc, a target gene of PKCα [28] . As shown in Figure 4 , c-myc was also decreased by aloeemodin. As we know, c-myc is an immediate early gene encoding transcription factors expressed in the G 1 phase of the cell cycle and has a DNA-binding property. Furthermore, the inhibition of c-myc by antisense oligomers has been shown to inhibit cell proliferation [29] . From this experiment, it is well established that aloe-emodin has a downregulatory effect on the expression of c-myc in human cervical cancer cells (Figure 4) . Since c-myc is the downstream target of the PKC pathway, this effect may be through the PKCα pathway.
Taken together, aloe-emodin can affect cell growth, cell cycle, and ALP activity of human cervical cancer cells in vitro.
